SCHEMBL19833162

SCHEMBL19833162

B(c1cccc(-c2ccccc2)c1)c1cccc(-c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.47
▸ MGLL Q99685 3/20 0.43
▸ HDAC8 Q9BY41 2/20 0.41
▸ KMO O15229 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ PRSS1 P07477 1/20 0.40
▸ PRSS2 P07478 1/20 0.40
▸ PRSS3 P35030 1/20 0.40
▸ AGXT P21549 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HSD17B1 P14061 1/20 0.39
▸ HSD17B2 P37059 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ HSP90AA1 P07900 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10031017 0.93 MAOA (0.43) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL26039430 0.93 MAOA (0.43) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL26188948 0.85 TAAR1 (0.58) MAOAALDH1A1MEN1KMT2ACYP3A4
SCHEMBL16363786 0.81 RAB9A (0.44) ALDH1A1HDAC2KDM4ELMNAHPGD
SCHEMBL10263396 0.80 MGLL (0.45) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL20319075 0.80 MAOA (0.44) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL2731883 0.76 ALDH1A1 (0.69) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL29354148 0.76 ALDH1A1 (0.69) MAOAALDH1A1MGLLHDAC8KMO
SCHEMBL2401076 0.76 ALDH1A1 (0.69) MAOAALDH1A1MGLLHDAC8KMO
Biphenyl SCHEMBL11687528 0.76 ALDH1A1 (0.69) MAOAALDH1A1MGLLHDAC8KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766975-B2 Catalyst compositions and use thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-09-08 — — US disclosed
WO-2018022238-A1 CATALYST COMPOSITIONS AND USE THEREOF EXXONMOBILE CHEMICAL PATENTS INC. (US) 2018-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766975-B2 Catalyst compositions and use thereof SOD1, NOX3, NOX4 MAOA 311/4885ALDH1A1 1317/4885MGLL 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback